Skip to content

Drug interactions

Linagliptin + Ritonavir

Severity: Minor

Linagliptin and Ritonavir: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ritonavir inhibits CYP3A4 and P-glycoprotein and may raise linagliptin levels modestly, though linagliptin has a wide safety margin. Protease inhibitors can also cause insulin resistance and hyperglycemia, which may offset glucose control.

What this interaction means in plain words

Linagliptin and Ritonavir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Linagliptin belongs to Endocrine; Ritonavir belongs to Anti Virals.

Evidence level: Moderate

Why it happens

Ritonavir inhibits CYP3A4 and P-gp, slightly increasing linagliptin exposure, while protease inhibitors can independently impair insulin sensitivity.

What to do

No linagliptin dose change is generally needed. Monitor blood glucose during ritonavir therapy and adjust antidiabetic treatment as required.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Linagliptin and Ritonavir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Linagliptin with Ritonavir?

MediHelp rates the interaction as minor. Linagliptin and Ritonavir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ritonavir inhibits CYP3A4 and P-glycoprotein and may raise linagliptin levels modestly, though linagliptin has a wide safety margin. Protease inhibitors can also cause insulin resistance and hyperglycemia, which may offset glucose control.

How serious is the interaction between Linagliptin and Ritonavir?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No linagliptin dose change is generally needed. Monitor blood glucose during ritonavir therapy and adjust antidiabetic treatment as required.

What other medicines interact with Linagliptin?

MediHelp also lists interactions of Linagliptin with, for example, Alogliptin-pioglitazone, Amlodipine-benazepril, Amobarbital. The full list is on the Linagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in